2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Second STOP After Pioglitazone Priming in CML PatientsChronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, hematologic disorder, leukemia, myeloid leukemia, neoplasmRecruitingPhase 22026-07-06NCT02889003
Improvement of Symptoms After Removal of the Essure® Contraceptive ImplantContraceptive Device; Complications; Implant ComplicationRecruitingNot applicable2026-04-13NCT06355713